SULJE VALIKKO

Englanninkielisten kirjojen poikkeusaikata... LUE LISÄÄ

avaa valikko

Elizabeth Hernberg-Ståhl | Akateeminen Kirjakauppa

Haullasi löytyi yhteensä 2 tuotetta
Haluatko tarkentaa hakukriteerejä?



Orphan Drugs : Understanding the Rare Disease Market and its Dynamics
Elizabeth Hernberg-Ståhl; Miroslav Reljanovic
Woodhead Publishing (2013)
Kovakantinen kirja
167,50
Tuotetta lisätty
ostoskoriin kpl
Siirry koriin
Orphan Drugs : Understanding the Rare Disease Market and its Dynamics
Elizabeth Hernberg-Ståhl; Miroslav Reljanovic
Woodhead Publishing (2018)
Pehmeäkantinen kirja
167,50
Tuotetta lisätty
ostoskoriin kpl
Siirry koriin
Orphan Drugs : Understanding the Rare Disease Market and its Dynamics
167,50 €
Woodhead Publishing
Sivumäärä: 334 sivua
Asu: Kovakantinen kirja
Julkaisuvuosi: 2013, 31.10.2013 (lisätietoa)
This authoritative and comprehensive book makes the reader familiar with the processes of bringing orphan drugs to the global market. There are between 5,000 and 7,000 rare diseases and the number of patients suffering from them is estimated to be more than 50 million in the US and Europe. Before the orphan drug legislation enacted in the US in 1983, there was a limited interest from industry to develop treatment for very small patient groups. One of the difficulties is, of course, that similar levels of investment are needed from a pharmaceutical company to bring a drug to the market for both small and large patient groups.The journey from application of an orphan drug designation to a reimbursed market- approved drug is long and many obstacles occur during the journey.After reading the book, readers will: Understand who the players/stakeholders are in the rare orphan disease field and their specific needs and concerns: patients and patient organizations, researchers and treating physicians within the field, industry, regulatory and reimbursement bodies* Understand the strong partnership between the different players and the various initiatives to improve and increase access to treatment for patients; minimizing the gap between numbers of known diseases, orphan designations, approved drugs and paid drugs.The book also provides short practical case stories from patients and researchers, as well as representatives from industry and authorities on the challenges they came across in developing orphan drugs or getting access to orphan drugs.


  • A comprehensive overview of strategy, key activities and considerations of how to bring an orphan drug from concept to the market and make it available to patients
  • A source of updated information, news and trends for those who are already active in this fast-evolving field
  • Covers the global definitions and the criteria for getting an orphan drug designation in, for example, the US and Europe


Tuotetta lisätty
ostoskoriin kpl
Siirry koriin
LISÄÄ OSTOSKORIIN
Tilaustuote | Arvioimme, että tuote lähetetään meiltä noin 1-3 viikossa.
Myymäläsaatavuus
Helsinki
Tapiola
Turku
Tampere
Orphan Drugs : Understanding the Rare Disease Market and its Dynamicszoom
Näytä kaikki tuotetiedot
ISBN:
9781907568091
Sisäänkirjautuminen
Kirjaudu sisään
Rekisteröityminen
Oma tili
Omat tiedot
Omat tilaukset
Omat laskut
Lisätietoja
Asiakaspalvelu
Tietoa verkkokaupasta
Toimitusehdot
Tietosuojaseloste